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Although  an  immunologic basis  for the pathogenesis of human  acute  and 
chronic  glomerulonephrifis has  enjoyed wide  popularity  because  of  certain 
clinical  observations  (1--9)  and  laboratory  experiments  (10-14),  there  has 
been, until  recently, no convincing laboratory model to produce  glomerulo- 
nephritis in animals by means of an autoimmune  mechanism. 
Most attempts to produce experimental animal nephritis by immunological models 
have centered chiefly on the production of nephritis by single or repeated intravenous 
injections of foreign protein (15-17), antigen-antibody complexes (18), or anti-kidney 
antibodies  (13).  Heteronephrotoxic sera have been considered  to be highly species 
specific (19, 20),  but Steblay and Lepper (21) have shown  that rabbit antihuman 
glomerular  basement membrane serum will produce nephritis in dogs. We have con- 
firmed this original observation and extended it to include numerous other examples 
of cross-reactions.  All the above models are valuable in contributing to our under- 
standing of how alternate experimental methods may damage glomernli.  However, 
they all fail to provide evidence  for the crucial  step postulated in the autoimmune 
theory, namely, the se/f-production of antibodies  and/or antibody-bearing (sensitized) 
cells by the host specific for an antigen which  is  a  normal constituent of its own 
glomernlar  tissue. The self-produced antibody and/or sensitized cell is capable of ini- 
tiating injury to the antigen-containing  tissue. 
Many efforts have been made to produce a plausible  autoimmune model. Diverse 
autologous,  homologous, or heterologous kidney preparations with various adjuvants 
have been injected into several species. Such efforts have been largely frnifless;  and 
one early report of success (22) has not been confirmed (23). Recently, Heymann (24) 
has reported the production of the nephrotic syndrome in rats by repeated intraperi- 
toneal injection of homologous or autologous  rat kidney tissue in Freund's complete 
adjuvant; and Hess (25) has reported the transfer of this rat renal disease by means 
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of lymph node cells from donor rats with induced disease  into healthy tolerant re- 
cipients. 
An experimental model which appears to satisfy the requirements/or an autoim- 
mune mechanism has been described for a growing list of readily reproducible labora- 
tory diseases. These experimental diseases have been produced by injections  of suitably 
prepared mammalian tissues incorporated in Freund's complete adjuvant into certain 
susceptible species. The tissues used/or producing specific organ damage include cen- 
tral and peripheral nervous tissue,  uvea, adrenal, testis, and thyroid. In some cases 
(central and peripheral nervous tissue, thyroid, lens, and uvea) heterologous tissue can 
be used (26). Regardless of the nature of the antigenic stimulus, whether auto-, iso-, 
homo-, or heteroimmunization  has been used, the host's own tissue constituents, anti- 
genically related to the injected antigen, serve as the target organ. 
In  an  effort  to  produce  an  experimental  autoimmune  glomerulonephritis 
based on the preceding model, glomerular basement membrane, prepared from 
kidneys of human, monkey, rabbit, rat, or dog, was incorporated with Freund's 
adjuvant and injected by various routes  into several different species.  This 
paper  reports  evidence for  the  successful production of  a  fatal,  fulminating 
extracapi]lary glomerulonephritis in adult female sheep  which  is  remarkably 
similar to various stages of glomerulonephritis in man. 
Materials and Methods 
Human glomeruli were isolated  from  kidneys  obtained  from patients  who  underwent 
sudden violent death.  Monkey, rabbit, rat, and dog giomeruli were obtained from healthy 
animals sacrificed for their kidneys. Glomerular basement membrane (GBM) was prepared 
from isolated glomeruli by the previously described (27) slightly modified method of Krakower 
and Greenspon (28). Human giomeruli preparations contained the least amount of tubules, 
capsules and interstitial tissue, while the rabbit preparations  contained the most  tubules 
and capsules. Preparations containing large amounts of tubules and capsules were discarded. 
The GBM was homogenized in isotonic saline with the sonic oscillator  1 for 3 to 5 minutes 
and made up to a concentration of 20 to 50 mg (wet weight) per ml. Merthiolate was added 
to give a final concentration of 1:10,000. The homogenized suspension was slowly added to 
Freund's complete adjuvant  * to form a 1:1 water-in-oil emulsion. The final concentration of 
GBM in the emulsion varied from 10.3 mg per ml to 26.7 mg per ml, but most preparations 
contained about 25 mg per ml emulsion. 
A human placenta was obtained shortly after birth, freed of membranes and washed free 
of blood in the gross. It was homogenized in a Waring blendor with equal weights of saline 
and then incorporated  with an equal volume of Freund's adjuvant. Additional saline was 
added until the final concentration of the placenta in the water-in-oil emulsion was 5 gm per 
30 ml. Because of the high concentration of large tissue particles, this preparation  did not 
form a very stable or smooth emulsion. 
1  Raytheon sonic oscillator, model S102A, 50 watt, 9 kc; Raytheon Co., Waltham, Massa- 
chusetts. 
2 Freund's complete adjuvant: Arlacel A., 15.0 ml; bayol F, 85.0 ml, Mycobacterium butyrl- 
cure (Difco), 100 mg. Arlacel A: Atlas Powder Co., Wilmington. Bayol F: Penola Division, 
Detroit. RAYMOND  WILLI.A~  $TEBLAY  255 
Young Hampshire ewes, weighing about 120 to 140 pounds, were obtained from different 
herds through a  local veterinarian. The sheep were housed in three different environments 
and given food from three different commercial sources. There were five different experimental 
groups of animals. The following results are the composite of these different experiments. A 
total of thirty-two sheep were employed. 
After having been found free of overt disease and with normal urine and blood urea nitro- 
gen, the sheep were injected every 2 weeks with 6 to 15 ml of emulsion containing approxi- 
mately 100 to 240 mg of GBM. Each sheep received GBM from a single species. The average 
amount of GBM per injection was approximately 150 rag. It was given by a combination of 
intramuscular, subcutaneous, and intradermal routes at each administration. For example, 
10 ml of emulsion might be divided as follows: 5 ml intramuscularly in one hind leg, 2  ml 
subcutaneously in the axillary and inguinal regions on the same side, and 1 ml intradermally 
in the skin of the dorsum of the neck. 
A total of 30 ml of placental emulsion was similarly given by multiple routes every 2 weeks 
until sacrifice. 
Periodic urinalyses and blood urea nitrogen determinations were performed on some of 
the sheep during the course of immunization. The urine from some of  the sheep was col- 
lected in metabolism cages. An occasional casual specimen was obtained by chance from a 
sheep that urinated spontaneously. The urine protein was determined by the heat and acetic 
acid  method  and by  the sulfosalicylic acid  method.  Blood urea nitrogen, serum  albumin, 
globulin, and  cholesterol were  determined prior  to  injection and  at  death in  most  of  the 
sheep. 
At death,  complete autopsies were performed,  bladder urine analysed,  and the kidneys 
carefully examined in the gross and microscopically. Kidney and other tissues were fixed in 
ice cold  10 per cent formalin and stained with hematoxylin and eosin, periodic acid-Schiff 
reagent with alcian blue and Masson's trichrome stain. 
RESULTS 
Experiment  I.  Regular  Production  of a Fatal,  Fulminating  Glomeruloneph- 
ritis.-- 
In this experiment, ten sheep were injected with human or animal GBM and Freund's 
adjuvant until they died. Each sheep received 412 to 1419 mg of GBM from a single species 
in 3  to 6 injections. All sheep died 38 to 90 days after injections began. There was a  high° 
degree of uniformity in the results despite the variations in species origin of antigen, concentra- 
tion of antigen in emulsion, or the amount of emulsion injected 
The sheep died in uremia from renal failure characterized by blood urea nitrogen elevation 
greater than 350 mg per cent; 3  to 4+  proteinuria in urine obtained from the bladder or 
metabolism  cage;  and  microscopic  evidence  of  severe  glomerulonephritis. The  results  are 
summarized in Table I. 
The clinical course of the disease in these sheep appeared to be very short. It was not 
unusual for a  sheep to appear healthy within hours before death. One sheep, No.  2-7,  gave 
birth to a  live lamb 3  days before dying from severe renal damage in uremia. Some of the 
sheep became weak, lethargic, or lost weight a  few days before death. Two sheep developed 
tarry stools and at autopsy had tarry stool in the gut. One sheep developed dyspnea and had 
marked pulmonary edema at death. None of the sheep appeared edematous during life or at 
autopsy. 
The pathologic changes in the kidneys of all the sheep were similar, In the gross the kid- 
neys were large, pale, swollen, gray-brown, with petechiae scattered over the cortical and cut 
surfaces, The capsule stripped easily and the cortical surface was smooth. TABLE  I 
Comparison  of Renal  Histology,  Blood  Urea  Nitrogen,  Proteinuria,  and  Day  of Death  wi*h 
Type of Antigen, Amount,  Concentration  and Number of Injections 
Sheep  Antigen  No. 
1  Human 
GBM 
2  Human 
GBM 
3  Human 
GBM 
4  Human 
GBM 
1-7  Human  815 
GBM 
5  Monkey  412 
GBM 
7  Rabbit  483 
GBM 
2-A  Rat GBM  1032 
3-7  "  "  638 
1-8  Dog GBM  840 
9  Human 
placenta 
1-2  Human 
placenta 
8  Freund's  0 
adjuvant 
only 
1-4  Freund's  0 
adjuvant 
only 
1-5  Freund's  0 
adjuvant 
only 
2-2  Freund's  0 
adjuvant 
only 
2-3  Freund's  0 
adjuvant 
only 
2-4  Freund's  0 
adjuvant 
only 
2-9  Freund's  0 
adjuvant 
only 
Total  Total  ~ o  ~  Concen-  Day  Bladder Blood 
amount  ot  ~'~  tration of INo. of  of  urinary  urea  Renal  histology:~  ~  nitro-  antigen  antigen in  injee- death  protein  (wet wt.)  emulsion I tions  gen 
ml/in.-  mg/ml  mg/lO~ 
mg  iection  ml 
480  6  26.7  3  42  4+  ND  Chronic  glomer- 
ulonephritis 
1419  6  26.7  6  90  3+  372  Chronic  glomer- 
ulonephritis 
480  6  26.7  3  44  ND§  ND  Chronic  glomer- 
ulonephritis 
480  6  26.7  3  38  4+  428  Chronic  glomer- 
ulonephritis 
10  19.5  4  52  4+  378  Chronic  glomer- 
ulonephritis 
10  10.3  4  67  ND  240  u  Chronic  glomer- 
ulonephritis 
10  16.1  3  58  3+  390  Chronic  glomer- 
ulonephritis 
6  43.0  4  82  ND  ND  Chronic  glomer- 
ulonephritis 
7  25.0  4  45  4+  355  Chronic  glomer- 
ulonephritis 
15  13.8  4  50  ND  448  Chronic  glomer- 
ulonephritis 
25 gm  30  1 gm/6  5  100¶  trace  21  Normal limits 
ml 
40 gm  30  1 gm/6  8  112¶  0  14  "  " 
ml 
5-6 
10 
10 
10 
10 
10 
7 
4  100¶  0  21  .... 
8  112  1+  50  Focal  pyelone- 
phritis 
8  112  ND  17  Normal limits 
9  118  1+  22  .... 
9  118  3+  9  Questionable 
changes** 
9  118  trace  22  Normal limits 
10  126  0  19  .... 
* All injections were given by multiple portals: intramuscular, subcutaneous, and intra- 
dermal. 
:~ All kidneys grossly were swollen,  gray-brown,  and contained petechiae  on surface  in 
group given GBM and adjuvant. 
§ ND  =  Not done. 
[I This determination was done 6 days before death. 
¶ All the control sheep in the group given Freund's adjuvant alone were sacrificed, and all 
sheep given human placenta and Freund's adjuvant were sacrificed. 
** Changes were present in the glomeruli which were difficult to interpret. No petechiae 
were present. 
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Microscopic  findings  were  characterized by  various stages  of  glomerular obsolescence 
(Fig. 3). Fibrocellular proliferation of the giomerulus obliterated Bowman's space and made 
it difficult to delimit the various parts of the glomerulus  from  itself and the surrounding 
interstitial connective  tissue. There was  a  conspicuous  increase of  interstitial connective 
tissue and some areas of interstitial cellular infiltration. Casts of various types and blood 
were present in tubules. Tubular atrophy and dilatation were present. Various degenerative 
changes were seen in the tubules. Postmortem changes  sometimes obscured  these hlstologic 
changes. 
As controls,  seven sheep were given Freund's adjuvant alone. One of these sheep had a 
blood urea nitrogen of 50 mg per cent at sacrifice and renal histology compatible with pye- 
lonephritis, presumably unrelated to the experimental procedure.  Of the remaining six sheep, 
three had 1+ bladder-urinary protein for which no renal lesion could be found.  One sheep 
had 3+ proteinuria and mild giomerular changes  which were difficult to interpret. All the 
kidneys of the control sheep were of a normal borwn-purple color and size and did not show 
any petechiae on their surfaces  (Figs. 1 and 2). 
Two sheep  were  given injections of human placenta and  Freund's complete adjuvant. 
They were sacrificed 100 to 112 days after the first of 5 and 8 injections,  respectively. The 
kidneys were of normal size and color and had no petechiae. The bladder urine contained a 
trace and no protein, respectively, and the blood urea nitrogen was normal. 
It may be noted that the first four sheep in Table I  (Nos. l, 2, 3, 4) all received thesame 
antigen in an identical immunization schedule. Although three of these sheep died within 38 
to 44 days after the first of three injections, the fourth sheep died only after 90 days. The 
long-delayed death of this sheep illustrates that a variable host factor may be present. 
In summary, the chief result of this experiment was the regular production 
of a  fatal, fulminating diffuse subacute to chronic glomerulonephrifis within 38 
to 90 days after the first of 3  to 6 injections of human, monkey, rabbit, rat, or 
dog  GBM  in  Freund's complete adjuvant.  The  quantity of GBM  used from 
each  species was of the same  order of magnitude.  The  total weight of  GBM 
used varied from 412 to 1419 mg of GBM wet weight. A combination of intra- 
muscular, subcutaneous, and intradermal injections that totaled about 6  to 15 
ml of emulsion was given at each administration. Freund's complete adjuvant 
alone or in combination with human placental tissue (under the conditions of 
the present experiment) were unable to produce these results. 
Experiment  II. To Study the Effect of Varying the Route of Injection,  Number 
of Injections,  and Presence of Freund's  Adjuvant.--The  preceding experiment 
established  that  adult  female  sheep  injected  with  heterologous  GBM  and 
Freund's  adjuvant  regularly  develop  a  fulminating  glomerulonephritis.  The 
second experiment was designed to examine the effect of varying the route of 
injection, number of injections, and presence of Freund's adjuvant in producing 
glomerulonephritis. 
The same preparation of pooled HGBM was used throughout this experiment.  One sheep 
was given one injection of 50 ml of emulsion (25 mg HGBM/ml emulsion) by intramuscular, 
subcutaneous,  and intradermal routes. A total of 1.25 gm of HGBM was given. Two sheep 
were given intradermal injections of HGBM in saline w~hout adjuvant. 1 ml of HGBM in 
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locations every 2 weeks. One sheep  was given a total of 7 ml of emulsion (containing about 
175 mg of HGBM wet weight)  intramuscularly in two locations; another sheep  was given a 
total of 7 ml of emulsion subcutaneously in two locations, and three sheep  were given 1 ml 
intradermally in each of seven different sites every 2 weeks (concentration was 25 mg/ml in 
one sheep and 10 mg./ml, in two sheep.)  The sheep were followed with serial urinalyses and 
blood urea nitrogen and sacrificed when judged to have detectable nephritis. 
The results of this experiment are summarized in Table II. A  combination of HGBM 
and Freund's adjuvant by any single route was effective in producing a severe nephritis. The 
times of sacrifice were estimated to be a few days before spontaneous death would have oc- 
curred. All sheep had proteinuria, elevated BUN, petechiae on kidneys and marked glomeru- 
lar lesions.  The  disease  progressed  rapidly once proteinuria occurred  and  the  blood  urea 
nitrogen increased in an accelerated  fashion once azotemia began (vide infra). Although there 
were not enough sheep to compare statistically the efficiency of each route, it should be noted 
that all three sheep  given intradermal injections had developed  a  more fulminating disease 
than either of the sheep  injected by the other routes. It should be particularly noted that 
sheep  4-4 died within 27 days after only 2 injections and a  total of 120 mg of GBM. This 
finding is in keeping with a previously described  greater efficiency of the intradermal route 
in producing reactions of delayed hypersensitivity and autoallergic diseases  (29). 
Two sheep  were given a  total of 3.5 gm of HGBM in saline by the intradermal route in 
20 different injections (a total of 7 ml divided in 7 different locations at each injection) and 
have been followed for 10 months (at the time of this writing) and have not developed  pro- 
teinuria or an elevated blood urea nitrogen. The injection of HGBM without adjuvant is ap- 
parently incapable of producing nephritis, at least in a comparable period  of  time. 
The single sheep given one injection of  HGBM in Freund's adjuvant developed  2+ pro- 
teinuria on the 70th day in a casual urine specimen.  The sheep was sacrificed with a normal 
BUN because we were interested in obtaining an early lesion. Histopathologic evidence for 
glomerulonephritis was slight. In the gross  there were  only a few petechiae on the kidney. 
There was evidence of abnormal glomerular perrneabiliy which consisted of blood and casts 
in tubules. However,  the glomerular lesions were either very early or mild or both and were 
not diffuse, but consisted of focal acute proliferative glomerulonephritis. 
In summary,  the chief results of this experiment were  to  demonstrate  that 
subcutaneous, intramuscular, or intradermal routes of injection were all effec- 
tive in producing an extracapillary glomerulonephritis. There is suggestive evi- 
dence  that  the  intradermal  route  may be  the  most  efficient in producing  an 
earlier onset of death. Human GBM alone, without adjuvant, was ineffective in 
producing the disease,  at least after 20 injections over a  period of  10 months. 
Finally, one injection of HGBM  in Freund's adjuvant by all portals appears to 
have  produced  an early and/or mild focal proliferative glomerulonephritis at 
the time of sacrifice. Nothing can be said about the minimum amount of HGBM 
needed to produce disease,  since the smallest amount used,  a  total of  120 mg 
wet weight, given in two intradermal injections (10 mg/ml emulsion) was suffi- 
cient to produce a  fatal nephritis in 27 days. 
Experiment HI.  The Onset of Proteinuria, Onset and Rate of Progression  of 
Azotemia; Serum Proteins and Serum Cholesterol; and Serial ttistopathology.--In 
this experiment an attempt was made to ascertain certain features of the course 
of the disease. 
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TABLE H 
Comparison of Production of Nephritis with Route of Injection, Number of Injections, 
and Absence of Freund's Adjuvant 
Total  Con-  Blood  centra-  Total  Bladder  urea 
amount Amount  tion  No. of  Da~/of urinary  nitro-  Sheep of anti-  ~I emul- of anti-  • • 
No.  gen*  •  .  sacrifice  (wet  slon  gen m  mjec-  protein  gen at 
emul-  tions  sacrifice 
wt.)  sion 
rot~in-  mg  jection rag/ral 
2-5  700  7  25 
2-6  875  7  25 
2-7  525  7  25  3 
3-2  1250  5  25  1 
4-3  180  6  10  3 
4.4  120  6  10  2 
54  3+  112 
66  3+  58 
46  4+  420 
70  3+  24 
4111  4+  340 
2711  4+  375 
2-8  3500  0  0  20  10  0  19 
months 
2-8A  3500  0  0  20  10  0  24 
months 
Renal histology 
Subacute glomer-] 
ulonephritis 
Acute  to  sub- 
acute glomer- 
ulonephritis 
Subacute  to 
chronic  glo- 
merulonephri- 
tis 
Early:~ glomeru- 
litis 
Subacute  to 
chronic  glo- 
merulonephri- 
tis 
Subacute  glo- 
merulonephri- 
tis 
Normal 
Route of 
injection 
Intramus- 
cular 
Subcuta- 
neously 
Intrader- 
molly 
Multiple 
portals§ 
Intrader- 
really 
Intrader- 
molly 
Intrader- 
really¶ 
Intrader- 
molly¶ 
* All sheep were injected from the same pool of human glomerular basement membrane 
preparation. 
No definite glomerular lesion was seen; evidence of abnormal glomerular permeability 
was demonstrated by red cells and protein in Bowman's space and lumen of tubules. 
§ 40 ml was given intramuscularly, 8 ml subcutaneously, and 2 ml intradermally. 
II Died. 
¶ These injections were given without Freund's adjuvant; the antigen was suspended in 
saline at a concentration of 33.2 mg per ml saline. A total of 7 ml of suspension was given 
at each iniection: 1 ml was given in each of 7 different intradermal sites. 
The most striking change in the serum biochemical determinations is the increase in blood 
urea nitrogen in the animals given heterologous GBM and adjuvant (Table III). One control 
sheep which recieved Freund's adjuvant alone had a  BUN of 50 mg per cent but this was 
probably explained by a pyelonephritis presumably unrelated to the experimental procedure. 
The sheep were arbitrarily sacrificed  at different values of blood urea nitrogen to provide 
renal lesions of increasing severity or duration and are listed according to their increase in 
blood urea nitrogen determinations (Table III). There was no correlation between the BUN 260  GLOEERULONEPHRITIS  INDUCED  IN  SHEEP 
TABLE  III 
Correlation  of Renal Histology with Blood Urea Nitrogen. Comparison of Blood Urea Nitrogen, 
Serum Cholesterol, Bladder Urine Proteinuria, and Renal Histology with Kind 
of Antigen and Day of Sacrifice 
Sheep  Antigen 
No. 
2-6  Human GBM 
1-6  "  " 
2-5  .... 
3-3  Rat GBM 
1-1  Rabbit GBM 
1-0  Human GBM 
1-3  Rat GBM 
1-7  Human GBM 
2-7  .... 
1-8  Dog GBM 
I-A  Human GBM 
3-2  .... 
9  Freund's adju- 
vant only 
14  Freund's adju- 
vant only 
1-5  Freund's adju- 
vant only 
2-2  Freund's adju- 
vant only 
2-3  Freund's adju- 
vant only 
2-4  Freund's adju- 
vant only 
2-9  Freund's adju- 
vant only 
I 
Day of  Bladder 
sacrifice  urinary  protein 
Renal  histology 
66  3+  Acute  to  subacute 
glomerulonephritis 
84  4+  Subacute glomerulo- 
nephritis 
54  3+  Subacute glomerulo- 
nephritis 
74  ND  Subacute glomerulo- 
nephritis 
63  ND  Subacute glomerulo- 
nephritis 
50  3+  Subacute glomerulo- 
nephritis 
50  ND  Subacute glomerulo- 
nephritis 
52*  4+  Subacute to chronic 
glomerulonephritis 
46  4-4-  Subacute to chronic 
glomerulonephritis 
50*  ND  Chronic glomerulo- 
nephritis 
77  2-t-  Early~  glomerulo- 
nephritis  [ 
70  2+  Early§ glomerulitis  ' 
100  0  Normal limits 
112  1+  Focal pyelonephritis 
112  ND  Normal limits 
118  1+  Normal limits 
118  3-[-  Questionable changes 
118  trace  Normal limits 
126  0  Normal limits 
Preinjection  Blood chemis- 
blood  tries at death 
chemistries  or sacrifice 
Blood  Choles-  Blood  Choles- 
urea  terol  urea  tero!  nitrogen  ~nitrogen 
mg  mg  mg  mg 
per  cent  per  cent  per  cenl  per  een, 
27  66  58  83 
22  55  ]  91  91 
31  54  i  112  62 
147 
14  116  186  82 
i 
9  75  300  98 
14  95  345  85 
19  56  378  68 
23  64  ]  420  119 
25  38  I  448  63  i 
10  70  22  65 
i 
12  24 
26  50  21  30 
18  71  50  46 
I 
15  58  17  81 
20  68  22  52 
13  37  9  44 
i 
23  55  ]  22  33 
27  19 
Evidence of early glomerular inflammation with cellular  ~roliferation and presence of 
polymorphonuclears in glomerulus; abnormal glomerular permeability was present. 
§ No  objective changes in  glomeruli were  seen;  evidence of abnormal glomerular per- 
meability consisted of red ceils and protein in Bowman's space and lumen of tubules. 
* Died spontaneously. 
and day of sacrifice or death or any other serum biochemical determination. Serum albumin 
decreased and serum globulin increased in similar fashion in both the treated and control 
groups of sheep. 
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treated with heterologous GBM, this difference is not statistically significantly different from 
the control group. The sheep did not appear edematous during life or at death. They did not, 
therefore, have the nephrotic syndrome. 
Onset of proteinuria  (incubation  or latent period)  and azotemia: 
Serial urinary protein determinations were made on urine samples from some of the sheep. 
In column 3, Table IV, are tabulated the day after injection that the last negative urine for 
TABLE  IV 
The l~xperimentally Determined Range, in Days, of the Onset of Proteinuria and Azotemia and 
the Estimated Day of Onset of Proteinuria and Azotemia 
Sheep 
No. 
1-6 
1-7 
1-8 
2-5 
2-6 
2-7 
1-0 
1-1 
1-3 
5 
3-2 
1-A 
4-3 
4-4 
Antigen 
Human GBM 
Dog GBM 
Human GBM 
cl  it 
Rabbit GBM 
Rat GBM 
Monkey GBM 
Human GBM 
~4  tg 
~  g4 
Range in 
clays onset 
of protein° 
urla 
64  to  77 
10  to  30 
36  to  44 
40  to44 
40  to  46 
14  to  34 
31  to  60 
1  to  70 
1  to  77 
16  to  22 
12  to  20 
Estimated  Esti- 
mated or 
day of on-  actual 
set of pro-  day of 
teinuria  death 
71  92* 
20  52~ 
4o  s0~ 
42  65* 
43  79* 
24  47* 
--  53* 
--  68* 
51" 
45  65~ 
<70  70§ 
<70  77§ 
19  41ll 
16  27~ 
Time of 
latent 
period 
l~ef C~ 
77 
39 
8O 
65 
55 
51 
45 
59 
Range in 
days of 
onset of 
azotemia 
76  to  80 
29  to  42 
29  to  42 
1  to  45 
59  to  66 
1  to  45 
42  to  49 
55  to  62 
1  to  42 
1  to  60 
>70 
>77 
30  to  34 
14  to  21 
Estimated 
day of 
azotemia 
78 
37 
41 
43 
60 
35 
44 
57 
41 
50 
>70 
>77 
31 
17 
Duration 
of time 
to onset 
of 
azotemia 
p~C~nt 
85 
72 
82 
66 
76 
75 
83 
84 
81 
77 
74 
63 
Per cent latent period calculated as follows: (days to onset of proteinuria/days to onset 
of death) X  100. 
Per cent time to onset of azotemia as follows: (days to onset of azotemia/days to onset of 
death) X  100. 
* Estimated. 
Died. 
§ Sacrificed, 
I] Sacrificed when moribund. 
protein was obtained and the day the first positive urine for protein was obtained. This is 
given as the range of days within which proteinuria must have developed. The midpoint of 
this range was considered the estimated day of onset of proteinurla. 
The range of these midpoints which approximate the onset of proteinurla (latent period) 
was 16 to 71 days. The latent period thus estimated varied from 39 to 80 per cent of the total 
time from first injection to death with an average value of 59 per cent. 
The onset of proteinurla, as estimated, was found to occur on the average about 23 days 
before death with a  range of  10 to 32 days among the animals which died. The time from 
onset of proteinurla to death may then be relatively short. 
The day after injection on which the last normal BUN was determined and the first eleva- 262  GLO~RULONEPHRITIS  INDUCED IN  SHEEP 
sion was found similarly gives the experimentally determined range of days within which 
azotemia had its onset. These days are given in column 7, Table IV. The actual experimental 
curves of increase of nitrogen retention in nine sheep are given in Text-fig. 1 where sufficient 
serial BUN determinations have been performed to give a  picture of the time of onset and 
rate of progression of nitrogen retention. These curves were used to estimate the day of onset 
of azotemia and day of death in sheep with infrequent data as follows:  the experimentally 
TExT-FIG.  1.  Curves  illustrating  the  rate  of  increase  of nitrogen retention for  an  in- 
dividual sheep are shown. Although the onset of azotemia (BUN 35)  varies widely, from 32 
to 75  days for the sheep on this graph, the slopes of the progressive increase in BUN are 
quite similar in form, and it can be easily  seen that with a few experimental points, a curve 
can be extrapolated parallel to these curves extending to a hypothetical onset (BUN  =  35) 
and estimated day of death (BUN =  400). 
determined values of BUN and day of occurrence were plotted on a graph as in Text-fig. 1. 
A  curve was "fitted" through the experimental points similar in  shape  to experimentally 
determined curves. The fitted curve was then extrapolated to BUN values of 35  (onset) and 
400  (elevation at  which death arbitrarily was assumed to occur). This gives an estimated 
range of onset of azotemia of about 17 to 78 days after the first injection. The period of time 
to onset of azotemia is estimated to vary from 63 to 84 per cent of the total time from first 
injection to death. 
The onset of azotemia is estimated to occur about 9 to 22 days before death with an average 
value of about  13  days. A rising blood urea nitrogen was thus indicative of terminal renal 
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Once nitrogen retention occurred, the daily rate of increase in blood urea nitrogen appeared 
to accelerate in a progressive  fashion  so that the higher the blood urea nitrogen, the more 
rapidly it rose each day. The sudden progressive acceleration of nitrogen retention and rapid 
culmination in death defines the fulminating character of this induced sheep renal disease. 
Serial histopathology of the renal lesions: 
Although a  detailed description of the evolution of the renal lesion will be 
given elsewhere, a  brief description of the pertinent histologic changes will be 
given here. 
As would be expected,  the severity of the renal lesions of the sacrificed animals is pro- 
portional to the height of the blood urea nitrogen elevation (Table III). The earliest lesions 
from animals with proteinuria and normal blood urea nitrogen appeared to be an acute extra- 
capillary proliferative glomerulonephritis  with casts and blood in tubules, colloid droplet 
degeneration of  tubules,  and increased numbers  of polymorphonuclear leukocytes in glo- 
merular loops. The earliest changes were primarily in the glomeruli with increased glomerular 
permeability and secondary degenerative changes in tubules. No significant change in tubular 
architecture or interstitial tissue was seen at this stage. 
As the disease further progresses, some of the giomeruli become scarred and obsolescent 
and begin to resemble those seen in chronic glomerulonephritis (Figs. 7 and 8). 
In the subacute stage there is marked fibro epithelial proliferation of the glomerulus (cres- 
cent formation) which gradually obliterates Bowman's space and makes it difficult to delimit 
the various parts of the glomerulus  from itself and the surrounding interstitial connective 
tissue. There is a conspicuous increase in interstitial connective  tissue and interstitial cellu- 
lar infiltrates, chiefly mononuclear  cells but occasionally  polymorphonuclear  cells. Casts of 
various types and blood are present in tubules. Atrophy and dilatation of tubules were present. 
The sheep which died had the most advanced renal lesions and usually had varying numbers 
and degrees of glomerular obsolescence (Figs. 4, 5, and 6). 
In summary, proteinuria and azotemia began, on the average, about 23 days 
and  13  days, respectively, before death. The rate of increase of azotemia was 
progressive and accelerated. The course of the disease was fulminating. Serum 
albumin decreased and  serum  globulin increased in both  treated and control 
sheep. Serum cholesterol values were not satistically significantly different be- 
fore and after injection either in treated or control (Freund's adjuvant alone) 
sheep. The characteristic histologic lesion was an extracapillary glomeruloneph- 
riffs with severe and progressive formation of crescents.  The  crescents  even- 
tually involved all glomeruli and  the glomeruli rapidly developed glomerular 
obsolescence. Marked  tubular and  interstitial changes  occurred  secondary to 
the glomerular lesions. 
Experiment  IV. Some  Immunologic  Studies  on Sera from Sheep  Which De- 
veloped Nephritis. 
A.  Passive transfer studies in rats and dogs: 
Sera were obtained from sheep after injections with either rat or dog GBM. The antisera 
were heated to 56°C. for ~  hour and then absorbed for 2 hours at room temperature with an 
equal volume of rat or dog washed red cells. About 0.5 ml of sheep anti-rat GBM serum was 
injected intravenously into 24 rats weighing about  170  gln.  An immediate proteinuria and 264  GLOMERULONEPHRITIS  INDUCED  IN  SH-EEP 
detectable glomerular lesions were present within a few hours in all the rats (30). The sheep 
anti-dog GBM serum was injected intravenously  into six dogs at a dosage of 0.3 ml/pound 
dog weight and produced an immediate nephritis within 6 hours in all the dogs. It was evident 
that the serum of a sheep with fulminating nephritis contained potent ncphrotoxic antibodies 
for the species producing the antigen used in immunizing the sheep. 
B.  Fluorescent-labeled  antibody  studies: 
Antisera were obtained from sheep that had been injected with either rat or human GBM 
and Freund's adjuvant until a fulminating nephritis developed. Gamma globulin fractions of 
the antisera were conjugated  to fluorescein isothincyanate according to the method of Riggs 
et al. (31). 4/~ sections of human or rat kidney were cut from frozen, unfixed pieces of human 
or rat kidney on a cryostat.  The fluorescein conjugates were passed through  a Dowex resin 
column and absorbed with mouse liver powder and human or rat blood. Staining of sections 
with fluoresecin conjugates and inhibition controls were performed as described by Coons (32). 
Sheep anti-rat or anti-human  GBM fluorescein-labeled gamma globulin stained  the base- 
ment membranes of the glomeruli, tubules,  Bowman's capsules and intertubular  capillaries 
and certain  extracellular structures  in the media and advenfitia  of arteries of rat or human 
kidney tissue sections, respectively, in ~itro (33) (Fig. 9). 
Antibodies which are capable of localizing on the basement membrane struc- 
tures of the heterologous kidney antigen are evidently circulating in the serum 
of a  sheep with fulminating nephritis. 
Passive  transfer  studies  of sheep  antisera  in  lambs  and  fluorescein-labeled 
antibody studies with autologous and homologous sheep kidney tissue sections 
are in progress and will be reported later. 
DISCUSSION 
It is well known that  Freund's adjuvant  alone may disseminate  within  the 
body and  form lesions  in various  organs  (34).  The possibility  that  adjuvant 
alone might produce some glomerular injury and increased glomerular perme- 
ability accounting for the presence of mild proteinuria (l+)  in three sheep and 
3+  proteinuria and focal glomerular lesions in another control sheep was con- 
sidered.  Two sheep  were given injections  of placenta  and  Freund's  adjuvant 
without producing proteinuria or renal lesions. The injection of a combination 
of heterologous GBM and Freund's adjuvant,  therefore, has a  unique effect in 
inducing  a  new,  previously  unknown,  uniformly  fatal  glomerulonephritis  in 
sheep. 
The experimental  model used  to produce  this  new experimental  glomerulo- 
nephritis  is responsible  for inducing a  number  of so called  "autoimmune  dis- 
seases"  and consists of injecting certain susceptible  species with  suitably pre- 
pared tissue in Freund's adjuvant. Either autologous, homologous, or heterolo- 
gous tissue  has  been used,  but regardless  of the antigenic  stimulus,  the host's 
own immune response is directed at some antigenic constituent of its own tissue 
in the target organ, closely related to the antigen injected. 
Waksman has aptly coined the term "autoallergic" for this group of labora- RAYMOND  WILLIA.M  STEBLAY  265 
tory autoimmune diseases and has characterized their properties in a compre- 
hensive review (26).  We wish to classify the sheep nephritis described in this 
paper as having an autoimmune basis as previously discussed (35). 
Attempts to passively transfer the nephritis in sheep and other species by 
sheep anti-rat GBM, anti-dog GBM, and anti-human GBM sera are in prog- 
ress.  Preliminary attempts to transfer nephritis by these sera in sheep have 
been unsuccessful so far. On the other hand, these same antisera will produce 
immediate severe nephritis when injected intravenously into rats (30) or dogs 
(vide supra). Although it is well known that such heterologous anti-kidney sera 
are nephrotoxic for the species providing the kidney, this is the first example 
that we are aware of where the animal which produced the nephrotoxic serum 
developed nephritis itself.  Moreover, the observation that the highly potent 
nephrotoxic sera is not able, at least so far, to produce nephritis when injected 
intravenously into other sheep, suggests that the circulating nephrotoxic anti- 
bodies for rat or dog kidney may not have a role in the sheep disease. 
Gamma globulin obtained from sera of sheep injected with human GBM, 
conjugated to fluorescein isothiocyanate, can stain the BM structures of human 
kidney (dde supra). Such antisera are also, in preliminary studies, incapable of 
transferring nephritis to other sheep. 
It may be concluded that the circulating antibodies which localize in human 
kidney or which are nephrotoxic for rats and dogs are present in high concen- 
tration in the sera of sheep with nephritis which was induced by the correspond- 
ing GBM antigens. It is, however, purely speculative as to whether such dem- 
onstrated  localizing  or  nephrotoxic  antibodies  have  any  role  in  the  sheep 
nephritis. Waksman (26) has pointed out that passive transfer of serum from 
animals with autoallergic diseases has consistently failed to produce disease in 
the same or different species.  It is thus important to remember that, whereas 
successful transfer of nephritis by serum from sheep with nephritis to other 
species appears  to be  the first exception to  this generalization, we have not 
demonstrated that such serum antibodies are important in the pathogenesis of 
the sheep disease. Conclusive proof that the sheep nephritis is produced by an 
autoimmune mechanism rests upon successful passive transfer of the nephritis 
in the same species by serum antibody and/or sensitized cells. 
Heymann (24)  has described a  renal lesion in rats resulting from intraperi- 
toneal injections of rats with autologous or isologous rat whole kidney emulsion 
and Freund's adjuvant. Several observations in his results and those presented 
in this paper are either different or in marked contrast: the renal lesions in the 
sheep were quite different from the rat lesions which were described or pub- 
lished by Heymann; the rats developed a nephrotic syndrome with characteris- 
tic serum biochemical changes and a histological lesion of membranous glomeru- 
lonephritis; the diseased rats lived much longer than 3 months after the first 
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the first injection; the rat disease could be produced only by intraperitoneal 
injection. Parenteral routes were said to be ineffective. We did not try intra- 
peritoneal injections in the sheep but any of the portals described in this paper 
were effective. Heymann has further reported that tubercle bacilli were effective 
but Mycobacterium  butyricum  as adjuvant was not. On the other hand, we have 
found Mycobacterium butyricum to be quite effective in sheep. Heymann used 
autologous or isologous whole rat kidney emulsion as antigen in contrast to the 
heterologous GBM antigen preparations used in this report. The renal disease 
in the rats has been reported by Hess (25) to be transferred by lymph node cells 
to suitably tolerant recipient rats. This would appear to establish the rat dis- 
ease as having an autoimmune basis and being mediated by sensitized cells. 
The fatal nephritis described in this paper, however different it may be from 
the above induced rat nephrotic syndrome, is most probably based on an auto- 
immune mechanism. In the absence of successful passive transfer of an experi- 
mental disease in the same species by serum antibody and/or cells,  Waksman 
(26) has listed the following criteria as characterizing the immunologic basis for 
the mechanism of the autoimmune diseases: the production of lesions in organs 
corresponding to the tissues used in immunization, presence of a latent period, 
specificity of lesion in that it occurs only in regions where antigen is accessible 
in  suitable  concentrations,  histologic  appearance  resembling  the  tuberculin 
reaction, diminution of the autoallergic state with  time,  anamnestic reaction 
and  susceptibility of the disease  to steroid therapy. Not all  of these criteria 
apply to the present sheep disease, but based upon consideration of the above 
kind of criteria used to characterize the autoallergic diseases, the most reason- 
able  explanation for  the  observed  sheep  kidney damage  is  an  autoimmune 
mechanism. 
It has been frequently postulated that the important tissue antigens in the 
autoallergic diseases  are  characterized as  being  separated  from  the  blood or 
lymph stream by more or less anatomic or physiological barriers. The body is 
presumably not really tolerant to the "autoantigen" but merely harboring a 
hidden antigen, sheltered from exposure to the antibody-forming centers. 
However, in the case of the immunizing antigen in autoimmune sheep nephri- 
tis, the antigen used was a greatly concentrated or purified preparation of hu- 
man or animal GBM. This is a tissue constituent normally exposed to the blood 
stream through fenestrations in the glomerular endothelium. The human GBM 
has been reported to be present (Dr. Robert Vernier, personal communications) 
in the fetal kidney at 2 months.  The presence of glomerular basement mem- 
brane structures in the fetus suggests that the fetus has ample opportunity to 
develop  tolerance to  glomerular  basement  membrane  constituents.  Further, 
the adult animal with its blood stream normally intimately exposed to GBM, 
would be expected to  be highly tolerant indeed of its  own  GBM.  However, 
heterologous GBM might vary sufficiently to appear "foreign" enough to the 
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"closely related" antigens in the host's own kidney GBM. Further, the act of 
preparing GBM might sufficiently alter the important antigen in the basement 
membrane preparation so  as to render it somewhat more  "foreign" and yet 
sufficiently related to produce the cross-reacting response. 
If this be so, we might predict that the autologous and homologous GBM 
preparations, unless sufficiently altered by the process of preparation, might 
not be as potent an antigen in producing autoimmune nephritis as heterologous 
GBM. We are in the process of testing this hypothesis by injecting sheep with 
autologous and homologous sheep GBM and Freund's adjuvant. 
Recently, Weigle (36) reported that immunological tolerance induced in rab- 
bits by neonatal injections of bovine serum albumin (BSA)  can be terminated 
by a  series  of injections of certain heterologous serum albumins which cross- 
react with BSA. Injections of heterologous albumins, distantly related to BSA, 
were more effective in producing a  loss  of tolerance for BSA than albumins 
closely related were. If it is assumed that tolerance induced in neonatal rabbits 
to BSA is similar to tolerance induced during fetal life to their own body con- 
stituents, e.g. glomerular basement membrane, then injections of heterologous 
albumins which cross-react  with  the  albumins used  to  induce  tolerance  are 
analogous with injections of heterologous GBM in sheep which are tolerant to 
their own GBM. It is possible that animals may lose tolerance to their own 
body constituents by some manner as yet unknown by exposure to antigens 
which cross-react with their own body constituents; i.e., which have simultane- 
ously some degree of similarity and yet foreign quality. Whether the heterol- 
ogous GBM induces an immune response which cross-reacts  with autologous 
GBM, or whether the immune response is somewhow induced by the autologous 
constituents is unknown. 
The reason for the parallel changes in serum albumin, globulin, and choles- 
terol of the GBM-treated group of sheep and the control (Freund's adjuvant 
alone) group is unknown. The increase in globulin in the treated group may be 
explained by the increase in gamma globulin from immunization. The parallel 
rise in gamma globulin in the control group may be due to the non-specific in- 
flammatory effect of Freund's adjuvant or its ability to produce an immune 
increase in gamma globulin. Prolonged immunization has been reported to pro- 
duce a marked increase in serum gamma globulin and a fall in serum albumin 
concentration. This has been demonstrated by Bjorneboe (37) following hyper- 
immunization of rabbits with pneumococcal vaccine. 
Thus the parallel hypoalbuminemia in the control sheep may be due to an 
immunizing  effect of  Freund's  adjuvant  alone.  Perhaps  the Mycobacterium 
butyricum  in the adjuvant or altered tissue at site of injection acts as an antigen. 
The changes in serum cholesterol are not statistically significant although there 
appears to be a trend towards elevated serum cholesterol in the GBM-treated 
group. 
The explanation for the length and variation in the latent period is specula- 268  GLOMIERULONEPHRITIS INDUCED IN SHEEP 
tive. It appears to be due to variation in time for the autoimmune mechanism 
to get started. Once started, however, the renal lesion progresses rapidly. The 
curves of increase of nitrogen retention indicate a rapidly accelerating process; 
and the rate of increase of BUN plus the rapid evolution of the renal lesion from 
acute through subacute to chronic lesions resulting in death from uremia charac- 
terize the disease as a fatal fulminating one. 
The early lesion in the typical autoallergic diseases is characterized by a peri- 
venous collection of mononuclear cells  (38).  These cells are thought to be the 
mediators of tissue damage in areas of sequestered antigen by some unknown 
mechanism. On the contrary, in the sheep nephritis, the antigen is part of the 
glomeru]ar basement membrane and directly exposed to the immunologic me- 
diator of damage. The lesion starts then in the glomerular capillaries. The extra- 
ordinary feature of the lesion is the marked fibroepithelial proliferation (crescent) 
which appears to originate largely from Bowman's capsule. 
It is unlikely that the technique described in this paper is related to an anti- 
gen-antibody complex mechanism such as Dixon has employed in producing 
glomerulonephritis in rabbits (17). The bulk of evidence in the autoallergic dis- 
ease suggests each disease is mediated by cells (sensitized or antibody-bearing), 
but the evidence in the sheep nephritis is incomplete for either vector. Decisive 
experiments to determine whether antibody and/or sensitized cells are the vec- 
tor mediating the glomeru]ar damage are in progress. 
SUMMARY 
Sheep injected every 2 weeks with heterologous GBM and Freund's adjuvant 
by any one or combination of the following routes: intramuscular, subcutaneous, 
or intraderma], develop uniformly a  fulminating, extracapi]]ary glomerulone- 
phritis, invariably fatal within 27 to 90 days after the first injection. 
The chief  histologic feature is marked fibroepithelial proliferation  of Bow- 
man's capsule with crescent formation. The appearance of the lesions resembles 
the acute, subacute, and chronic stages of human glomerulonephritis, and de- 
pends on when the animal was sacrificed. 
Freund's  adjuvant  or  heterologous  GBM  alone  does  not  produce  such  a 
nephritis. The combination of placental tissue and Freund's adjuvant under the 
present experimental conditions was also unable to produce a nephritis. 
The clinical course, increase in nitrogen retention, evolution of renal lesions, 
and death, all describe a fulminating disease. The disease most characteristically 
resembles fatal, fulminating human subacute glomerulonephritis. 
The changes in serum proteins, decrease in serum albumin, and increase in 
serum globulin, occurred approximately the same in both the GBM-treated and 
the control adjuvant group. Similar changes have been reported from hyperim- 
munization a]one, and so it is not clear how much these changes are due to im- 
munization and how much is due to the nephritic process. The changes in serum 
cholesterol were not considered statistically significant. RAYMOND  WILLIAM  STEBLAY  269 
Circulating serum antibodies which localized (by fluorescent antibody tech- 
nique in ~itro) on basement membrane structures of the heterologous donor kid- 
ney antigen or which produced nephritis in the heterologons donor species (rat 
and dog) were found in serum of sheep sick or dying of nephritis. The passive 
transfer of nephritis by serum antibodies marks the first successful instance of 
transfer of nephritis by serum antibody to a heterologous species from an ani- 
mal which had developed nephritis itself. The serum antibodies involved in the 
transfer of disease to the donor species appear to be unrelated to the mediators 
of nephritis in the sheep and may represent only the previously known hetero- 
nephrotoxic antibodies. By various biologic criteria  the sheep nephritis pre- 
sumably occurs  by  an  autoimmune mechanism. However,  it  is  not known 
whether the sheep nephritis is mediated by sensitized cells and/or antibodies. 
The latent period was estimated to end about 16 to 71 days after the first in- 
jection. Azotemia was estimated to begin about 17 to 78 days after the first in- 
jection. Proteinuria and azotemia began approximately 23 and 13 days before 
death. The rapid progression to  a  fatal termination defined the fulminating 
character of this disease. 
The author is indebted to Dr. Mark H. Lepper, Department of Preventive Medicine,  Uni- 
versity of Illinois College of Medicine, Chicago, and to Dr. M. Edward  Davis, for invalu- 
able assistance; to Dr. Robert Jenn;ngs  and the Armed Forces Institute of Pathology for aid 
in interpreting the histopathology;  and to Mr. Ulrich Rudofsky  for technical assistance. 
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EXPLANATION OF PLATES 
PLATE 26 
FIG.  1.  Kidney of sheep picked at random from stockyards. Sheep estimated to be 
in cold room 5 to 6 hours after death. Normal tubular, capsular, and glomerular archi- 
tecture  can  be  seen.  Postmortem  changes obscure  some  details.  Hematoxylin  and 
eosin.  ×  750. 
FIG.  2.  Kidney of a control sheep, No. 9, given 6 injections of Freund's adjuvant 
alone. It was sacrificed  100 days after injections began. The section shows a normal 
pattern of kidney architecture and demonstrates the normal basis of reference for size 
and structure of glomeruli, capsules, and tubules. Note lack of interstitial connective 
tissue and interstitial  cellular infiltrates.  Masson's trichrome stain.  ×  200. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL.  116  PLATE 26 
(Steblay: Glomerulonephritis induced in sheep) PLAT1" 27 
FIG.  3.  Kidney taken from sheep  2A which  was  injected 4  times with a  total of 
1032 mg of rat  GBM. The sheep  was  found dead on day 82.  It had melena shortly 
before  death  and  tarry  stool  was  present  in  the  gastrointestinal tract  at  autopsy. 
Postmortem changes obscure the picture but the marked increase  in connective tissue 
inside the  glomerulus, in  the  periglomerular area,  and  intertubular  intersfitium is 
evident. Hematoxylin and eosin.  ×  550. 
FIG.  4.  Kidney section from sheep  1-6 which was sacrificed on (lay 84 after 6 injec- 
tions of a  total of  1192 mg of human GBM. Most glomeruli have varying degrees of 
fibroepithelial proliferation of Bowman's capsule (early crescent formation). There is 
hyaline droplet degeneration and casts in some of the tubules. There are focal areas of 
interstitial fibrosis but tubular architecture is relatively intact. The BUN was 91. l'his 
is an early proliferative extracapillary glomerulonephritis.  PAS.  X  100. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 116  P~ATE  27 
(Steblay: Glomerulonephritis induced in sheep) PLATE  28 
FIG.  5.  Kidney section from sheep  1-0 which  was  injected 4  times with a  total of 
912  mg of human  GBM.  The  sheep  was  sacrifced  on  day  50  with  a  BUN of  300. 
Marked fibroepithelial proliferation of Bowman's capsule (crescent formation)  is pres- 
ent. The glomerular tuft is compressed, hypercellular, and areas of nccrosis and  infil- 
tration of polymorphonuclear cells can be seen in it. Blood and casts are present in the 
tubules.  There is an increase in connective tissue and mononuclear cell infiltration  in 
the  interstitial  spaces.  The  similarity  to  human  subacute  glomerulonephritis  is  evi- 
dent.  Hematoxylin and eosin.  X  320. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 116  PLATE  28 
(Steblay: Glomerulonephritis induced in sheep) PLATE  29 
FIG.  6.  Kidney section from sheep  1-3  which was injected 4  times witb a  total of 
952  mg of rat GBM. The sheep was sacrificed on (lay 50 with a  BUN of 345. There is 
marked fibroepithelial proliferation inside the original Bowman's capsule. The fibrillary 
part of the newly proliferating connective tissue can be seen in the extensive crescent 
which is compressing the original glomerular tuft.  Masson's trichrome.  N  500. 
FIo.  7.  Kidney from sheep 2-7 which was sacrificed 46 days after the first of 3 in- 
jections of a  total of 525  mg of HGBM. The most prominently staining membrane  is 
probably the original Bowman's capsule. New fibers can be seen arising or proliferating 
from  it.  The  extensive fibroepithelial proliferation obliterating Bowman's space  and 
fusing with the extensive periglomerular connective tissue can be seen.  l)ilated tubules 
are present.  This glomerulus is obsolescent.  PAS.  X  700. THE  JOURNAL  OF  EXPERIMENTAL MEDICINE  VOL. 116  PLATE 29 
(Steblay: Glomerulonephritis induced in sheep) PLATE 30 
FIG.  8.  Kidney section taken from sheep 1-0 which was sacrificed  50 days after lhe 
first of 4 injections of a total of 912 mg of HGBM. The BUN was 300. Two obsolescent 
glomeruli can be seen.  Remnants of the original Bowman's capsule can be seen  with 
irregular and disrupted outlines. The extensive fibrous proliferation inside and outside 
the glomerulus can  be seen.  Casts  are present  in  some of the  dilated  tubules.  PAS. 
X 350. 
FIo.  9.  Human  kidney section  treated  with fluorescein-labeted sheep anti-human 
GBM  gamma  globulin.  The  basement  membrane  of  Bowman's  capsule,  glomeruli, 
tubules, and intertubular capillaries and certain extracellular structures in  the media 
and adventitia of arteries are specifically stained with the fluorescent conjugates. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  116  PLATE  30 
(Steblay: Glomerulonephritis induced in sheep) 